Hammerco Lawyers has filed a class action lawsuit on behalf of Canadian residents in light of Health Canada’s drug recall advisory on March 9.
Multiple lots of Losartan-containing drugs are being voluntarily recalled by Teva Canada, Apotex Inc., Pharmascience Inc., and Pro Doc Limitée because of the potential for a nitrosamine impurity, N-Nitroso-N-methyl-4-aminobutyric acid (NMBA).
NMBA is potentially a human carcinogen, which means that long-term exposure could increase the potential risk of cancer.
Please contact Kevin McLaren if you think you may have been affected by the Losartan drug recall.
More News & Resources
November 7, 2024
Women make up more than half of the population in Canada, but when it comes to healthcare, they often face disproportionate challenges and struggle to receive the care they deserve.
November 7, 2024
Hammerco Partner Alexia Majidi recently settled a case for a courageous woman who endured life-altering injuries during what was supposed to be a routine and uncomplicated hysterectomy.
November 1, 2024
Hammerco Lawyers initiated a class action lawsuit against Cencora Inc. and Innomar Strategies Inc. about a data breach where sensitive personal and personal health information of patients was accessed.
October 31, 2024
We are proud to share that Hammerco Lawyers has been recognized in the prestigious inaugural 2025 edition of Best Law Firms™ - Canada.